Acura Pharmaceuticals (ACUR)
|
2.19
-0.05 (-2.23%)
|
|
|
|
ACUR additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACUR Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
Vanguard Extended Market Idx
iShares Russell 2000 Growth Index
EQ/Small Company Index IA
CREF Stock
AXA Tactical Manager 2000-II IB
EQ/AllianceBern Small Cap Growth IB
TFS Market Neutral
Fidelity Spartan Extended Mkt Index Inv
VALIC Company I Small Cap Index
CREF Equity Index
iShares Russell 2000 Growth Index
EQ/Small Company Index IA
CREF Stock
AXA Tactical Manager 2000-II IB
EQ/AllianceBern Small Cap Growth IB
TFS Market Neutral
Fidelity Spartan Extended Mkt Index Inv
VALIC Company I Small Cap Index
CREF Equity Index
•
Executives
Mr. Robert B. Jones
Chief Exec. officer
Pres and Director
Mr. Peter A. Clemens
Chief Financial Officer
Principal Accounting Officer Sr. VP of Investor Relations and Sec.
Mr. Robert A. Seiser
VP
Treasurer and Corp. Controller
Dr. Albert W. Brzeczko Ph.D.
VP of Technical Affairs
Mr. J. Bradley Rivet
VP of Marketing
Chief Exec. officer
Pres and Director
Mr. Peter A. Clemens
Chief Financial Officer
Principal Accounting Officer Sr. VP of Investor Relations and Sec.
Mr. Robert A. Seiser
VP
Treasurer and Corp. Controller
Dr. Albert W. Brzeczko Ph.D.
VP of Technical Affairs
Mr. J. Bradley Rivet
VP of Marketing
•
Employee Count
15
Special Offers
Competitors
ACUR earnings
No earnings releases available.
